Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(29)
•••
Comment by elgin1on Feb 11, 2020 11:37pm
60 Views
Post# 30678009

RE:RE:RE:Stock20 try link CVM on ASE USA

RE:RE:RE:Stock20 try link CVM on ASE USA
BioTeck wrote: Ok thanks for the information medvic. I will buy as much as I can tomorrow! Thanks for joining this board and bringing such valuable knowledge.
medvic1 wrote: 0.31c and even lower was before 1:25 split. From my 30k shares 1200 left but I bought much more at $2.83.
Anyway it's not about CVM but about SVA as not many see what they can miss here. 
People, buy it under .20c with two hands. Remember, there's no cure for diabetes and if this devises prove to be working - expect big pharma to grab Sernova as soon as at the end of the year. My opinion only and have to dig a bit more in Sernova.  
jwallisca wrote: CEL-SCI Corporation (NYSE American: CVM) , a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive Officer, will be presenting at the 2020 BIO CEO & Investor Conference in New York, NY on Monday, February 10, 2019 at 3:45 p.m. A live audio webcast ...

https://www.baystreet.ca/quotedata/CVM/fullnewssummary/

CVM in US of Hey :)


n.b. I didn't see any 31 cent stuff in the charts, but I did see considerable sub - one dollar closes.

 




Bioteck,

Medivic might be right and buying under 20 cents with both hands .... he sees huge benefit vs risk. Good for him. Bioteck your sarcasm and negativity and bias towards Sva is always on display.  What are you going to do when ( not if ) Medivics investment thesis is correct ? 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities